 | Up a level |
Canivell, S; Mohaupt, M; Ackermann, Daniel; Pruijm, M; Guessous, I; Ehret, G; Escher, G; Pechère-Bertschi, A; Vogt, B; Devuyst, O; Burnier, M; Martin, P-Y; Ponte, B; Bochud, M (2018). Copeptin and insulin resistance: effect modification by age and 11 β-HSD2 activity in a population-based study. Journal of endocrinological investigation, 41(7), pp. 799-808. Kurtis 10.1007/s40618-017-0807-7
Gennari-Moser, C; Khankin, E V; Escher, G; Burkhard, F; Frey, B M; Karumanchi, A S; Frey, F J; Mohaupt, M G (2012). OS067. VEGF, a novel stimulator of aldosterone production. Pregnancy hypertension, 2(3), p. 213. Elsevier 10.1016/j.preghy.2012.04.068
Mohaupt, MM; Draeger, A; Escher, G (2011). Statin-Unverträglichkeit - Aktuelle Alternativen zur Standardtherapie. Cardiovasc(10), pp. 10-12. Prime Public Media AG
Ackermann, Daniel; Vogt, B; Escher, G; Dick, B; Reichen, J; Frey, B M; Frey, F J (1999). Inhibition of 11beta-hydroxysteroid dehydrogenase by bile acids in rats with cirrhosis. Hepatology, 30(3), pp. 623-629. Wiley Interscience 10.1002/hep.510300303
